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Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as significant healthcare-
associated multidrug-resistant pathogens across the United States.1 Klebsiella pneumoniae 
carbapenemase-producing Enterobacteriaceae (KPCs) are the primary organisms of 
antibiotic resistance for this type of infection in the US.2 Bacterial strains that harbor 
carbapenem resistance genes have shown resistance to all known first line therapeutic 
options and the threat of the spread of these organisms is of great concern to the US 
healthcare system.3 Colonization and infection with KPCs have been associated with several 
healthcare-associated factors, and an increase in associated morbidity and mortality has been 
documented.4
Despite its notoriety, the true burden of KPCs is unknown. The colonized patient is an 
important reservoir of CREs and represents a key to understanding the spread and control of 
these organisms. In this study, we determined the colonization prevalence of KPCs in a 
cohort of mechanically ventilated patients residing in all healthcare settings (acute and long 
term care) by performing a statewide prospective cross-sectional prevalence survey to 
determine the burden of KPCs in Maryland.
All healthcare facilities that provide care to mechanically ventilated patients in Maryland 
were invited to participate; participation was voluntary. The prevalence survey was 
performed during a 12-day period from July-August 2010. Each facility collected peri-anal 
and sputum samples from eligible patients. The survey was performed as a public health 
initiative and no patient identifying information was collected. Peri-anal cultures were 
obtained using Staplex II cotton swabs (Staplex) and sputum cultures were collected during 
routine respiratory care. All samples were analyzed for a previous study and frozen at 
−70°C.5 The samples were thawed and the detection of KPCs was performed following the 
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CDC method.6 Susceptibility testing and amplification and sequencing of blaKPC was 
performed on all isolates.7,8 Multi-locus sequence typing was performed on KPC-producing 
Klebsiella pneumoniae and Escherichia coli isolates to determine strain relatedness.
Forty (70%) of the 57 eligible healthcare facilities within 5 regions of Maryland participated 
in the survey (Figure 1); 30 (67%) of the eligible acute care facilities and 10 (83%) of the 
eligible LTC facilities. Among the 40 facilities that participated, five facilities (four acute 
care and one LTC) did not have an eligible/ventilated patient during the study period and 
therefore no specimens were collected. Characteristics of participating facilities were 
published previously.5
Among participating facilities, there were 390 patients eligible to be enrolled and 
surveillance cultures were obtained from 358 (92%). KPC-producing genes were detected in 
22 bacterial isolates from 20 (6%) patients (5 sputa and 17 peri-anal; Table 1). Two patients 
had KPCs detected in both the sputum and peri-anal specimen. KPCs were isolated from 
patients in 9 (23%) healthcare facilities, 4 acute care and 5 LTC facilities. Eleven (55%) of 
the 20 patients resided in a LTC facility. KPCs were found in two regions of Maryland. 
Culture detected 15 K. pneumoniae, 6 E. coli, and 1 Enterobacter cloacae. Of these isolates, 
19 harbored the blaKPC-2 and 3 harbored the blaKPC-3. Molecular typing revealed three 
different K. pneumoniae strains found in 4 acute care and 3 LTC facilities. Of the K. 
pneumoniae isolates, 60% (9/15) were ST 258 found in 6 healthcare facilities (3 acute care 
and 3 LTC). There were four different E. coli strains detected in 4 facilities (1 acute care and 
3 LTC). Of the E. coli 50% (3/6) were ST 131 found in 1 acute care and 2 LTC facilities. 
One facility had KPC producing K. pneumoniae, E. coli, and E. cloacae detected harboring 
either the KPC-2 or KPC-3 gene.
We found that mechanically ventilated patients have a high prevalence of KPCs within a 
variety of healthcare facilities in Maryland. We showed that 6% of patients from 40 acute 
care and LTC facilities in Maryland were colonized with KPC-producing 
Enterobacteriaceae. 55% of the KPCs were found in LTC facilities. KPCs were found 
primarily in peri-anal swabs but in three patients, KPCs were only found in the sputum. 
These CREs were detected exclusively in the central and national capital regions in 
Maryland, which are more populated areas with a higher number of healthcare facilities. 
Molecular typing data showed transmission of organisms within and between healthcare 
facilities.
KPCs are emerging as a serious threat within the US, yet the true burden is unknown. In 
2012, the CDC reported that 4.6% of acute care hospitals reported at least one CRE from 
clinical cultures.9 However, previous to this study, no statewide active surveillance of the 
true burden of CREs has been reported anywhere in the nation. Thibodeau et al performed a 
voluntary, statewide, paper-based survey on clinical cultures in Massachusetts hospitals and 
found that nearly half of all Massachusetts hospitals detected a CRE in 2010 and that these 
CREs were more often detected in teaching hospitals than non-teaching hospitals.10 
However, the use of clinical cultures only as well as the use of differing definitions of CREs 
make it difficult to interpret the Massachusetts results. In our study we collected surveillance 
peri-anal and sputum cultures and used enrichment techniques to determine the prevalence 
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of KPCs utilizing identical laboratory methods and definitions for each facility. We also 
performed molecular typing on bacterial strains harboring KPCs and revealed a dominant 
strain type for both K. pneumoniae and E. coli.
This study has several limitations. We could not rule out response bias since only 70% of the 
healthcare facilities participated in survey. At the time of this study, the importance of urine 
as a specimen to detect CREs was unknown therefore we might have missed patients 
colonized with KPCs. In addition, this point prevalence was limited to patients receiving 
mechanical ventilation, who are known to have higher rates of colonization, and therefore 
the KPC prevalence cannot be generalized to other patients populations.
In conclusion, this is the first study to our knowledge to examine the colonization rate of 
KPCs in a cohort of mechanically ventilated patients residing in both acute and long term 
care healthcare facilities in one state within the United States.
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Seventy (70%) of Maryland Healthcare centers with mechanically ventilated patients 
participated in the study. KPC-producing Enterobacteriaceae were found in 23% of 
facilities, which were located in 2 major regions of Maryland.
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Table 1
Characterization of Enterobacteriaceae-producing Klebsiella pneumoniae carbapeneamase.
Patient Facility FacilityType Region Specimen Organism
Sequence
Type blaKPC
1 1 LTC Central Maryland sputum K. pneumoniae 15 KPC-3
2 1 LTC Central Maryland peri-anal E. coli 167 KPC-2
3 2 LTC Central Maryland peri-anal K. pneumoniae 258 KPC-2
4 3 Acute Central Maryland sputum K. pneumoniae 258 KPC-2
5 3 Acute Central Maryland peri-anal E. coli 95 KPC-3
6 3 Acute Central Maryland peri-anal E. coli 131 KPC-2
7 3 Acute Central Maryland peri-anal E. cloacae NT* KPC-2
8 4 LTC Central Maryland peri-anal K. pneumoniae 258 KPC-2
9 4 LTC Central Maryland peri-anal E. coli 131 KPC-2
10 4 LTC Central Maryland peri-anal E. coli 167 KPC-2
11 5 LTC Central Maryland peri-anal E. coli 131 KPC-2
12 6 Acute National Capital peri-anal K. pneumoniae 258 KPC-2
13 7 Acute Central Maryland peri-anal K. pneumoniae 15 KPC-3
14-1 8 LTC National Capital peri-anal K. pneumoniae 258 KPC-2
14-2 8 LTC National Capital sputum K. pneumoniae 258 KPC-2
15 8 LTC National Capital peri-anal K. pneumoniae 340 KPC-2
16 8 LTC National Capital peri-anal K. pneumoniae 340 KPC-2
17 8 LTC National Capital peri-anal K. pneumoniae 258 KPC-2
18 9 Acute National Capital peri-anal K. pneumoniae 258 KPC-2
19-1 9 Acute National Capital peri-anal K. pneumoniae 258 KPC-2
19-2 9 Acute National Capital sputum K. pneumoniae 258 KPC-2
20 9 Acute National Capital sputum K. pneumoniae 258 KPC-2
*
NT: not tested
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